BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11325388)

  • 1. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
    Christian AJ; Goodwin AK; Baker LE
    Pharmacol Biochem Behav; 2001 Mar; 68(3):371-7. PubMed ID: 11325388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist.
    Baker LE; Prus AJ
    Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
    Depoortere R; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms.
    Goudie AJ; Baker LE; Smith JA; Prus AJ; Svensson KA; Cortes-Burgos LA; Wong EH; Haadsma-Svensson S
    Behav Pharmacol; 2001 Sep; 12(5):303-15. PubMed ID: 11710745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.
    Franklin SR; Baker LE; Svensson KA
    Psychopharmacology (Berl); 1998 Jul; 138(1):40-6. PubMed ID: 9694525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand.
    McElroy JF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):531-3. PubMed ID: 7916465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ; Girardon S; Monneyron S; Dekeyne A
    Neuropharmacology; 2000 Feb; 39(4):586-98. PubMed ID: 10728880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL; Alling KL
    Behav Pharmacol; 2000 Sep; 11(6):483-93. PubMed ID: 11103914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline.
    Lamas X; Negus SS; Nader MA; Mello NK
    Psychopharmacology (Berl); 1996 Apr; 124(4):306-14. PubMed ID: 8739545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
    Prus AJ; Baker LE; Meltzer HY
    Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M; von Euler G
    Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
    Sinnott RS; Mach RH; Nader MA
    Drug Alcohol Depend; 1999 Apr; 54(2):97-110. PubMed ID: 10217549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the nature of a 7-OH-DPAT discriminative cue: comparison with D-amphetamine.
    Varty GB; Higgins GA
    Eur J Pharmacol; 1997 Nov; 339(2-3):101-7. PubMed ID: 9473122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.